aspartic acid - CISMeF

Preferred Label : aspartic acid;

MeSH definition : One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.;

MeSH synonym : l aspartic acid; L-Aspartic Acid;

MeSH Hyperonym : ( -)-Aspartic Acid; (R,S)-Aspartic Acid;

MeSH hyponym : l-aspartate; aspartic acid, hydrochloride; magnesiocard; potassium aspartate; aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate; Magnesium Aspartate; disodium aspartate; ammonium aspartate; aspartate; sodium aspartate; dipotassium aspartate; monosodium aspartate; monopotassium aspartate; calcium aspartate; Mg-5-Longoral; aspartic acid, Magnesium-Potassium (2:1:2) salt; aspartic acid, hydrobromide; L Aspartate; Aspartate, Calcium; Aspartic Acid, Calcium Salt; Aspartate, Sodium; Aspartic Acid, Sodium Salt; Aspartate, Disodium; Aspartic Acid, Disodium Salt; Aspartate, Magnesium; Aspartic Acid, Magnesium (2:1) Salt; Aspartate, Monopotassium; Aspartic Acid, Monopotassium Salt; Aspartate, Monosodium; Aspartic Acid, Monosodium Salt; Aspartate, Potassium; Aspartic Acid, Potassium Salt; Aspartate, Ammonium; Aspartic Acid, Ammonium Salt; Aspartate, Dipotassium; Aspartic Acid, Dipotassium Salt;

MeSH CAS label : L-Aspartic acid;

MeSH Related Number : magnesium aspartate; monopotassium aspartate; potassium aspartate; sodium aspartate; aspartic acid, hydrobromide; aspartic acid, hydrochloride; aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate; aspartic acid, Magnesium-Potassium (2:1:2) salt; calcium aspartate; dipotassium aspartate; disodium aspartate; monosodium aspartate; ( -)-Aspartic acid; ammonium aspartate; 14007-45-5 (Potassium aspartate); 17090-93-6 (Sodium aspartate); 2001-89-0 (Dipotassium aspartate); 2068-80-6 (Magnesium aspartate); 21059-46-1 (Calcium aspartate); 5598-53-8 (Disodium aspartate); 56-84-8 (Aspartic acid); 72231-13-1 (Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate); 10139-86-3; 1115-63-5; 17585-59-0; 30697-27-9; 32259-99-7; 3792-50-5; 48MC6MXP9X; 5LK942W2PC; 617-45-8; 74X989P9A6; OC4598NZEQ; R17X820ROL; SV5R735TZQ; T9680JD4IY;

Registry Number MeSH : 56-84-8;

Related CAS MeSH : 3792-50-5 (Monosodium aspartate); 617-45-8 (( -)-Aspartic acid); 32259-99-7 (Ammonium aspartate); 30697-27-9 (Aspartic acid, hydrobromide); 17585-59-0 (Aspartic acid, hydrochloride); 10139-86-3 (Aspartic acid, Magnesium-Potassium (2:1:2) salt); 1115-63-5 (Monopotassium aspartate); SV5R735TZQ (Sodium aspartate); 5LK942W2PC (Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate); T9680JD4IY (Calcium aspartate); 74X989P9A6 (Dipotassium aspartate); 48MC6MXP9X (Disodium aspartate); R17X820ROL (Magnesium aspartate); OC4598NZEQ (Potassium aspartate);

MeSH annotation : D-ASPARTIC ACID is also available;

Wikipedia link : https://en.wikipedia.org/wiki/Aspartic acid;

Codes EINECS : 200-291-6;

Is substance : O;

medicament (CISMeF) : O;

UNII : 30KYC7MIAI;

InChIKey : CKLJMWTZIZZHCS-REOHCLBHSA-N;

Details

Origin ID

D001224;

UMLS CUI

C0004015;

ATC code(s)
- ferrous aspartate [ATC Code]
- magnesium aspartate [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- aspartic acid [Substance BNPC]
Currated CISMeF NLP mapping
- Aspartic Acid [NCIt concept]
- Aspartic acid [FMA entity]
- Aspartic acid (substance) [SNOMED CT concept]
- aspartic acid [SNOMED Notion]
- aspartic acid [International Nonproprietary Name]
Exact mapping(s) to DCI
- aspartic acid [International Nonproprietary Name]
Indexing information
- PAsp(DET) [MeSH Supplementary Concept]
- PEG-PAsp(Dox) [MeSH Supplementary Concept]
- aspartate-glutamate carrier [MeSH Supplementary Concept]
- aspartic acid receptor [MeSH Supplementary Concept]
- polyaspartoyl-L-arginine [MeSH Supplementary Concept]
Record concept(s)
- (+-)-Aspartic Acid [MeSH concept]
- Aspartate Magnesium Hydrochloride [MeSH concept]
- Magnesium Aspartate [MeSH concept]
- Mg-5-Longoral [MeSH concept]
- ammonium aspartate [MeSH concept]
- aspartate [MeSH concept]
- aspartic acid [MeSH concept]
- aspartic acid, Magnesium-Potassium (2:1:2) salt [MeSH concept]
- aspartic acid, hydrobromide [MeSH concept]
- aspartic acid, hydrochloride [MeSH concept]
- aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate [MeSH concept]
- calcium aspartate [MeSH concept]
- dipotassium aspartate [MeSH concept]
- disodium aspartate [MeSH concept]
- magnesiocard [MeSH concept]
- monopotassium aspartate [MeSH concept]
- monosodium aspartate [MeSH concept]
- potassium aspartate [MeSH concept]
- sodium aspartate [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2S,3S)-3-(3-(4-(trifluoromethyl)benzoylamino)benzyloxy)aspartate [MeSH Supplementary Concept]
- (4-(N-alpha-fluorenylmethoxycarbonyl-aspartic acid beta-amido)benzyl)EDTA tetra tert-butyl ester [MeSH Supplementary Concept]
- (N-pyridylmethylaspartate)oxovanadium(IV) [MeSH Supplementary Concept]
- 1,2-bis(beta-L-aspartyl)hydrazine [MeSH Supplementary Concept]
- 1-0-(L-beta-aspartyl)-beta-D-glucopyranose [MeSH Supplementary Concept]
- 2,4-bis(1-decyloxyethyl)deuteroporphyrinyl-6,7-bisaspartic acid [MeSH Supplementary Concept]
- 2,4-bis(1-tetrahydro-fulfuroxyethyl)-deuteroporphynyl(IX)-6-7-bisaspartic acid [MeSH Supplementary Concept]
- 2-(11-(nonyloxy)undec-8-enamido)succinic acid [MeSH Supplementary Concept]
- 2-aminopropane-1,2,3-tricarboxylic acid [MeSH Supplementary Concept]
- 3,4-dihydroxyhydrocinammic acid (l-aspartic acid dibenzyl ester) amide [MeSH Supplementary Concept]
- 3,4-dihydroxyphenylpropionic (aspartic acid) amide [MeSH Supplementary Concept]
- 3-chloroaspartic acid [MeSH Supplementary Concept]
- 3-hydroxyaspartic acid [MeSH Supplementary Concept]
- 3-methylaspartic acid [MeSH Supplementary Concept]
- 4-(N-acetylaspart-4-yl)amino-4,6-dideoxyglucose [MeSH Supplementary Concept]
- 4-O-(alpha-carboxy-2-nitrobenzyl)aspartic acid [MeSH Supplementary Concept]
- 4-methoxy-7-nitroindolinyl-D-aspartate [MeSH Supplementary Concept]
- 5-((5-(1-carboxymethyl-3-(2-chlorobenzylsulfanyl)-2-oxopropylcarbamoyl)thiophen-2-ylmethyl)sulfamoyl)-2-hydroxybenzoic acid [MeSH Supplementary Concept]
- 8-guanidinooctanoyl-Asp-2-(4-methoxyphenyl)ethylamide [MeSH Supplementary Concept]
- AKF 92-10 [MeSH Supplementary Concept]
- AKF 94 [MeSH Supplementary Concept]
- AR58 compound [MeSH Supplementary Concept]
- AR60 compound [MeSH Supplementary Concept]
- CM 269 [MeSH Supplementary Concept]
- Fmoc-RGD [MeSH Supplementary Concept]
- IEM1770 [MeSH Supplementary Concept]
- IEM1944 [MeSH Supplementary Concept]
- L-beta-threo-benzyl-aspartate [MeSH Supplementary Concept]
- LK565 [MeSH Supplementary Concept]
- MBS solution [MeSH Supplementary Concept]
- N-(((3S)-6-((4-carbamimidamidobenzoyl)oxy)-2,3-dihydro-1-benzofuran-3-yl)acetyl)-L-aspartic acid hydrate [MeSH Supplementary Concept]
- N-((6-nitrocoumarin-7-yl)methyl)-D-aspartic acid [MeSH Supplementary Concept]
- N-(2-aminoethyl)aspartic acid [MeSH Supplementary Concept]
- N-(2-naphthalenesulfonyl)aspartyl-(2-phenethyl)amide [MeSH Supplementary Concept]
- N-(3-indolacetyl)aspartic acid [MeSH Supplementary Concept]
- N-(6, 8-dimercaptooctanoyl)-L-aspartate - zinc [MeSH Supplementary Concept]
- N-acetylaspartate [MeSH Supplementary Concept]
- N-acetylaspartic acid di(3-dimethoxyphosphorylpropyl) ester [MeSH Supplementary Concept]
- N-acryloylaspartic acid [MeSH Supplementary Concept]
- N-alpha-tert-butyloxycarbonyl-aspartic acid gamma-fluorenylmethyl ester [MeSH Supplementary Concept]
- N-alpha-tert-butyloxycarbonylaspartic acid beta-fluorenylmethyl ester [MeSH Supplementary Concept]
- N-benzyloxycarbonyl-3-amino-5-carboxy-2-oxopent-1-yl 2,6-dichlorobenzoate [MeSH Supplementary Concept]
- N-carboxy-aspartic anhydride benzyl ester [MeSH Supplementary Concept]
- N-phosphonomethylaspartic acid [MeSH Supplementary Concept]
- N-succinylaspart-1-yl celecoxib [MeSH Supplementary Concept]
- PCI-27483 [MeSH Supplementary Concept]
- PMA protocol [MeSH Supplementary Concept]
- STHGAL solution [MeSH Supplementary Concept]
- T 6361 [MeSH Supplementary Concept]
- alpha,beta-poly(aspartic acid) [MeSH Supplementary Concept]
- alpha-tert-butyl aspartate [MeSH Supplementary Concept]
- anticataracticum [MeSH Supplementary Concept]
- arginine aspartate [MeSH Supplementary Concept]
- asparaginic acid alpha-tert-butyl ester copper (II) complex [MeSH Supplementary Concept]
- aspartic acid 4-methyl ester [MeSH Supplementary Concept]
- aspartic acid beta-naphthylamide [MeSH Supplementary Concept]
- aspartic acid diethyl ester [MeSH Supplementary Concept]
- aspartic semialdehyde [MeSH Supplementary Concept]
- aspartimide [MeSH Supplementary Concept]
- aspartycin [MeSH Supplementary Concept]
- aspartyl adenylate [MeSH Supplementary Concept]
- aspartyl-2-aminobutyric acid ethylbenzylamide [MeSH Supplementary Concept]
- aspartyl-deoxyadenosine monophosphate [MeSH Supplementary Concept]
- aspergillomarasmine A [MeSH Supplementary Concept]
- aspergillomarasmine B [MeSH Supplementary Concept]
- benzyloxyaspartate [MeSH Supplementary Concept]
- benzyloxycarbonyl-Asp-CH2OC(O)-2,6-dichlorobenzene [MeSH Supplementary Concept]
- benzyloxycarbonyl-aspartyl(O-methyl)fluoromethane [MeSH Supplementary Concept]
- benzyloxycarbonyl-aspartyl-(beta-tert-butyl ester)-bromomethylketone [MeSH Supplementary Concept]
- benzyloxycarbonyl-aspartyl-fluoromethane [MeSH Supplementary Concept]
- beta,beta-dimethylaspartic acid [MeSH Supplementary Concept]
- beta-D-aspartylaminomethylphosphonic acid [MeSH Supplementary Concept]
- beta-L-aspartyl-hydrazine [MeSH Supplementary Concept]
- beta-aspartyl phosphate [MeSH Supplementary Concept]
- beta-aspartyl-adenosine monophosphate [MeSH Supplementary Concept]
- beta-benzyl-beta-hydroxyaspartate [MeSH Supplementary Concept]
- beta-carboxyaspartic acid [MeSH Supplementary Concept]
- beta-cyclododecyl aspartate [MeSH Supplementary Concept]
- beta-ethylideneaspartate [MeSH Supplementary Concept]
- beta-fluoroaspartic acid [MeSH Supplementary Concept]
- beta-methoxyaspartic acid [MeSH Supplementary Concept]
- beta-methyleneaspartate [MeSH Supplementary Concept]
- bisubstrate inhibitor LL320 [MeSH Supplementary Concept]
- carboxymethylaspartic acid agarose [MeSH Supplementary Concept]
- cardioplegin [MeSH Supplementary Concept]
- chlorasquin [MeSH Supplementary Concept]
- copoly(aspartic acid-glutamic acid) [MeSH Supplementary Concept]
- copper aspartate [MeSH Supplementary Concept]
- diammine dicarboxylic acid platinum [MeSH Supplementary Concept]
- estradiol (E(2))-Asp-hexapeptide conjugate [MeSH Supplementary Concept]
- iminoaspartic acid [MeSH Supplementary Concept]
- inzolen [MeSH Supplementary Concept]
- magnesium-aspartate-procaine [MeSH Supplementary Concept]
- methasquin [MeSH Supplementary Concept]
- pentaaluminum pentadecahydroxide aspartyl-aspartyl-aspartic acid [MeSH Supplementary Concept]
- poly (3-morpholinopropyl) aspartamide [MeSH Supplementary Concept]
- poly(3-hydroxypropyl-propyl)asparamide [MeSH Supplementary Concept]
- poly(aspartamide) [MeSH Supplementary Concept]
- poly(ethylene glycol)-poly(cisplatin-aspartic acid) [MeSH Supplementary Concept]
- poly(ethylene oxide)-block-poly(2-hydroxyethylaspartamide) [MeSH Supplementary Concept]
- poly(ethylene oxide)-block-poly(beta-benzyl aspartate) [MeSH Supplementary Concept]
- poly-DL-succinimide [MeSH Supplementary Concept]
- prelox [MeSH Supplementary Concept]
- sodium-potassium-magnesium-aspartate-sorbitol [MeSH Supplementary Concept]
- sparfosic acid [MeSH Supplementary Concept]
- succinyl-aspartic acid alpha-(4-methylcoumaroyl-7-amide) [MeSH Supplementary Concept]
- succinyl-aspartic acid alpha-(4-nitroanilide) [MeSH Supplementary Concept]
- t-butyloxycarbonylaspartic acid alpha-benzyl ester [MeSH Supplementary Concept]
- taurizine [MeSH Supplementary Concept]
- ureidosuccinic acid [MeSH Supplementary Concept]
- ureidosuccinic acid dihydrazide [MeSH Supplementary Concept]
- zinc aspartate [MeSH Supplementary Concept]
- zinc-bis(hydrogenaspartate) [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Aspartic Acid [NCIt concept]
- Aspartic acid [FMA entity]
- Aspartic acid (substance) [SNOMED CT concept]
- aspartic acid [Substance BNPC]
- aspartic acid [International Nonproprietary Name]
- aspartic acid [SNOMED Notion]
Validated automatic mappings to BTNT
- acid d,l-aspart [Substance BNPC]
- d-aspartic acid [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients